Risk of Covid-19 with renin-angiotensin-aldosterone system medications

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2020年 / 1804卷 / 1期
关键词：
D O I：
10.1007/s40278-020-78440-2
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：11 / 11
相关论文
共 50 条
  • [31] Fallacies in medical practice: Renin-angiotensin-aldosterone system inhibition and COVID-19 as a Paradigm
    Triposkiadis, Filippos
    Boudoulas, Konstantinos Dean
    Xanthopoulos, Andrew
    Boudoulas, Harisios
    HELLENIC JOURNAL OF CARDIOLOGY, 2021, 62 (03) : 185 - 189
  • [32] The renin-angiotensin-aldosterone system inhibitors in COVID-19: from acidosis to ventilation and immunity
    Wan-Hui, Liao
    Gee-Gwo, Yang
    Maciej, Henneberg
    SWISS MEDICAL WEEKLY, 2020, 150 : w20444
  • [33] The renin-angiotensin-aldosterone system: Role in pathogenesis and potential therapeutic target in COVID-19
    Braga, Cassia L.
    Silva-Aguiar, Rodrigo P.
    Battaglini, Denise
    Peruchetti, Diogo B.
    Robba, Chiara
    Pelosi, Paolo
    Rocco, Patricia R. M.
    Caruso-Neves, Celso
    Silva, Pedro L.
    PHARMACOLOGY RESEARCH & PERSPECTIVES, 2020, 8 (04):
  • [34] Renin-Angiotensin-Aldosterone System (RAAS) Inhibitors and Coronavirus Disease 2019 (COVID-19)
    Albashir, Ahmed Abdalazim Dafallah
    SOUTHERN MEDICAL JOURNAL, 2021, 114 (01) : 51 - 56
  • [35] Cardiovascular Damage in COVID-19: Therapeutic Approaches Targeting the Renin-Angiotensin-Aldosterone System
    Lumpuy-Castillo, Jairo
    Lorenzo-Almoros, Ana
    Pello-Lazaro, Ana Maria
    Sanchez-Ferrer, Carlos
    Egido, Jesus
    Tunon, Jose
    Peiro, Concepcion
    Lorenzo, Oscar
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (18) : 1 - 18
  • [36] Renin-Angiotensin-Aldosterone System Inhibitors and COVID-19 Infection or Hospitalization: A Cohort Study
    Dublin, Sascha
    Walker, Rod L.
    Floyd, James S.
    Shortreed, Susan M.
    Fuller, Sharon
    Albertson-Junkans, Ladia
    Harrington, Laura B.
    Greenwood-Hickman, Mikael Anne
    Green, Beverly B.
    Psaty, Bruce M.
    AMERICAN JOURNAL OF HYPERTENSION, 2021, 34 (04) : 339 - 347
  • [37] Inhibitors of the renin-angiotensin-aldosterone system and COVID-19 in critically ill elderly patients
    Jung, Christian
    Bruno, Raphael Romano
    Wernly, Bernhard
    Joannidis, Michael
    Oeyen, Sandra
    Zafeiridis, Tilemachos
    Marsh, Brian
    Andersen, Finn H.
    Moreno, Rui
    Fernandes, Ana Margarida
    Artigas, Antonio
    Pinto, Bernardo Bollen
    Schefold, Joerg
    Wolff, Georg
    Kelm, Malte
    De Lange, Dylan W.
    Guidet, Bertrand
    Flaatten, Hans
    Fjolner, Jesper
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2021, 7 (01) : 76 - 77
  • [38] Activation of the renin-angiotensin-aldosterone system is associated with Acute Kidney Injury in COVID-19
    Dudoignon, Emmanuel
    Moreno, Nabila
    Deniau, Benjamin
    Coutrot, Maxime
    Longer, Romain
    Amiot, Quentin
    Mebazaa, Alexandre
    Pirracchio, Romain
    Depret, Francois
    Legrand, Matthieu
    ANAESTHESIA CRITICAL CARE & PAIN MEDICINE, 2020, 39 (04) : 453 - 455
  • [39] Effect of Renin-Angiotensin-Aldosterone System Blockers on Adverse Outcomes in COVID-19 Patients
    Vinod, Poornima
    Krishnappa, Vinod
    Rathell Jr, William
    Dogbey, Godwin
    Patel, Hiten
    Herzog, William
    CARDIOLOGY, 2024, 149 (06) : 551 - 560
  • [40] The interacting physiology of COVID-19 and the renin-angiotensin-aldosterone system: Key agents for treatment
    Lumbers, Eugenie R.
    Head, Richard
    Smith, Gary R.
    Delforce, Sarah J.
    Jarrott, Bevyn
    Martin, Jennifer H.
    Pringle, Kirsty G.
    PHARMACOLOGY RESEARCH & PERSPECTIVES, 2022, 10 (01):
12345